Journal of Cancer Metastasis and Treatment (JCMT) is an international peer-reviewed, open access, online journal.
Aims and Scope
The Journal of Cancer Metastasis and Treatment (JCMT) is an international, peer-reviewed, open-access journal dedicated to advancing research on cancer progression, metastasis, and therapeutic strategies. The journal publishes high-quality basic, translational, and clinical studies across solid and hematologic malignancies, with a particular emphasis on metastasis-driven disease biology and management.
JCMT aims to bridge fundamental discoveries with clinical applications to accelerate innovation and improve outcomes for patients with advanced cancer.
Core areas of interest include:
- Cancer biology and progression: Molecular, cellular, and genetic mechanisms underlying tumor initiation, evolution, and metastatic dissemination
- Metastasis research: Biology of metastatic spread, tumor microenvironment interactions, and strategies for metastasis prevention and intervention
- Therapeutic approaches: Systemic therapies (chemotherapy, targeted therapy, immunotherapy), radiotherapy, and surgical management of primary and metastatic disease
- Clinical outcomes and prevention: Epidemiology, risk assessment, and strategies for early detection and prevention of cancer progression
Interdisciplinary and emerging areas are strongly encouraged, including:
- Bioinformatics and computational biology for biomarker and therapeutic target discovery
- Systems and multi-omics approaches to tumor heterogeneity and microenvironment dynamics
- Precision oncology and personalized medicine
- Immunotherapy innovations (e.g., checkpoint blockade, cell-based therapies, cancer vaccines)
- Nanotechnology and advanced drug delivery systems
- Biomedical engineering and novel diagnostic or minimally invasive technologies
JCMT welcomes a broad range of article types, including Original Articles, Reviews, Systematic Reviews, Meta-Analyses, Technical Notes, Commentaries, Editorials, Perspectives, and Letters to the Editor.
Mission:
By integrating fundamental metastasis research with state-of-the-art basic and clinical advances, JCMT seeks to accelerate scientific and clinical progress, improve survival, and enhance the quality of life for patients with metastatic cancer.
Ownership
The journal is owned by OAE Publishing Inc.
Publishing Model
Gold open access. All articles published by JCMT are made freely and permanently accessible online immediately from the date of publication. For further information, please refer to Open Access.
Copyright and License to Publish
Articles in JCMT had been published under Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported (CC BY-NC-SA 3.0) by October 2017, whereas the Creative Commons Attribution 4.0 International (CC BY 4.0) was further adopted afterwards. The CC BY 4.0 allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license users are free to share (copy, distribute and transmit) and remix (adapt) the contribution for any purposes, even commercially, provided that the users appropriately acknowledge the original authors and the source.
Copyright is retained by authors. Authors are required to sign a License to Publish (which can be downloaded from the journal's Author Instructions), granting JCMT, which identifies itself as the original publisher, exclusive rights to publish their articles, and granting any third party the right to use the articles freely as long as the integrity is maintained and the original authors, citation details and publisher are identified.
Editorial Board
For more information about the editorial team, please refer to Editorial Board.
Peer Review
The journal adheres to a rigorous peer review process and undergoes single-blind peer review. For more details, please refer to Editorial and Peer Review Process and Peer Review Guidelines.
Publication Ethics Statement
Journal of Cancer Metastasis and Treatment is a member of the Committee on Publication Ethics (COPE). We fully adhere to its Code of Conduct and to its Best Practice Guidelines.
The Editors of this journal enforce a rigorous peer-review process together with strict ethical policies and standards to guarantee to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like, do arise. The Editors of Journal of Cancer Metastasis and Treatment take such publishing ethics issues very seriously and are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use CrossCheck (powered by iThenticate) to check submissions against previous publications.
Editorial Policies
All manuscripts submitted to JCMT should adhere to JCMT's Editorial Policies.
Journal Information and Statistics
- Launch date: April 15, 2015
- Publication model: Open access
- ISSN 2454-2857 (Online), ISSN 2394-4722 (Print)
- Digital archive: Portico
- Frequency: Continuously published
- DOI: 10.20517/2394-4722
Indexing & Archiving
- All articles published in JCMT are included in:
- ESCI
- Portico
- Worldcat
- ROAD
- BASE
- CNKI
- Wanfang
- Chaoxing "Domain" Publishing Platform
- JournalGuide
- Scopus
- Cite Factor
- JournalTOCs
- CAS
- J-Gate
- Embase
- ASCI
Contact
Please see our Contact Us page for details about different queries.
